Erin K. Babcock
机构：Ambrx (United States), Inhibrx (United States)
发表论文 2 篇 · 总被引 11 次 · h-index 1
代表论文
- Recombinant Alpha-1 Antitrypsin–Fc Fusion Protein INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study (2024 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 被引 10)
- Recombinant Human Alpha-1 Antitrypsin (AAT) Protein INBRX-101 Demonstrates Potential to Achieve Lung Penetration and Normal Functional Serum AAT Levels in Patients With AAT Deficiency (2023 · 被引 1)